1 Table of Contents

2 Introduction
2.1 Blood Glucose Meters Overview

3 Products under Development
3.1 Blood Glucose Meters - Pipeline Products by Stage of Development
3.2 Blood Glucose Meters - Pipeline Products by Segment
3.3 Blood Glucose Meters - Pipeline Products by Territory
3.4 Blood Glucose Meters - Pipeline Products by Regulatory Path
3.5 Blood Glucose Meters - Pipeline Products by Estimated Approval Date
3.6 Blood Glucose Meters - Ongoing Clinical Trials

4 Blood Glucose Meters - Pipeline Products under Development by Companies
4.1 Blood Glucose Meters Companies - Pipeline Products by Stage of Development
4.2 Blood Glucose Meters - Pipeline Products by Stage of Development

5 Blood Glucose Meters Companies and Product Overview
5.1 4a Medicom GmbH Company Overview
5.2 A. Menarini Diagnostics Srl Company Overview
5.3 Abbott Diabetes Care Inc Company Overview
5.4 Abbott Diagnostics Company Overview
5.5 Advanced Biosensors-Ohio LLC Company Overview
5.6 Advanced Medical Electronics Corp Company Overview
5.7 Animas Corp Company Overview
5.8 Arkal Medical, Inc. (Inactive) Company Overview
5.9 Arkray Inc Company Overview
5.10 Ascensia Diabetes Care Holdings AG Company Overview
5.11 Azurite Technologies, Inc. (Inactive) Company Overview
5.12 Bar-Ilan University Company Overview
5.13 Baylor University Company Overview
5.14 Biopeak Corp Company Overview
5.15 Biorasis Inc Company Overview
5.16 BioTex Inc Company Overview
5.17 Biovotion AG Company Overview
5.18 Brain Beat Ltd Company Overview
5.19 Brigham and Women's Hospital Company Overview
5.20 Cactus Semiconductor Inc Company Overview
5.21 CALISTO MEDICAL, INC. (Inactive) Company Overview
5.22 Callitas Therapeutics Inc Company Overview
5.23 Cardiff University Company Overview
5.24 CGM3 Ltd Company Overview
5.25 City, University of London Company Overview
5.26 Columbia University Company Overview
5.27 ConvaTec Group Plc Company Overview
5.28 Cyber Medical Ltd Company Overview
5.29 DarioHealth Corp Company Overview
5.30 Debiotech SA Company Overview
5.31 DexCom Inc Company Overview
5.32 DiaMonTech GmbH Company Overview
5.33 DIRAmed LLC. Company Overview
5.34 DirectSens GmbH Company Overview
5.35 Drayson Health Ltd Company Overview
5.36 Echo Therapeutics Inc Company Overview
5.37 Ecole Polytechnique Federale de Lausanne Company Overview
5.38 eLutions Integrated Systems, Inc. Company Overview
5.39 Emperra GmbH E-Health Technologies Company Overview
5.40 EyeSense GmbH Company Overview
5.41 Flowsion A/S Company Overview
5.42 Gili Medical Ltd Company Overview
5.43 Globe Medical Tech Inc Company Overview
5.44 GlucoLight Corporation (Inactive) Company Overview
5.45 GlucoMe Ltd Company Overview
5.46 Glucometrix AG Company Overview
5.47 Glucosat Company Overview
5.48 Glucosense Diagnostics Ltd (Inactive) Company Overview
5.49 GlucoSet AS Company Overview
5.50 GlucoStats System Pte Ltd. Company Overview
5.51 Glucovation Inc Company Overview
5.52 GluMetrics Inc Company Overview
5.53 Glusense Ltd Company Overview
5.54 GlySens Inc Company Overview
5.55 GlySure Ltd Company Overview
5.56 Grove Instruments Inc. (Inactive) Company Overview
5.57 G-Sense Ltd. Company Overview
5.58 iGlyko, Inc. (Inactive) Company Overview
5.59 Indian Institute of Technology Bombay Company Overview
5.60 Indigo Diabetes NV Company Overview
5.61 InLight Solutions Inc. Company Overview
5.62 Innovosens AB Company Overview
5.63 Innovus Pharmaceuticals Inc Company Overview
5.64 Institute of Biomedical Engineering (ISIB-CNR) (Inactive) Company Overview
5.65 Insulet Corp Company Overview
5.66 Integrated Medical Group of Irvine Company Overview
5.67 Integrity Applications Ltd Company Overview
5.68 IntelliDx Inc (Inactive) Company Overview
5.69 Invivomon Inc (Inactive) Company Overview
5.70 Invivosense ASA (Inactive) Company Overview
5.71 iSense Corporation (Inactive) Company Overview
5.72 KeenCAT Technologies Company Overview
5.73 Lein Applied Diagnostics Limited Company Overview
5.74 LEMM Technologies, LLC Company Overview
5.75 LifeScan Inc Company Overview
5.76 LighTouch Medical, Inc. Company Overview
5.77 Luminous Medical Inc (Inactive) Company Overview
5.78 Lyte Labs Company Overview
5.79 Massachusetts Institute of Technology Company Overview
5.80 Medical Wireless Sensing Ltd Company Overview
5.81 Medtronic plc Company Overview
5.82 Mellitor Ltd Company Overview
5.83 Metronom Health Inc Company Overview
5.84 Microchips Biotech Inc Company Overview
5.85 MIT Spectroscopy Lab Company Overview
5.86 mobiLIFE Company Overview
5.87 Mologic Ltd Company Overview
5.88 Nagasaki University Company Overview
5.89 Nemaura Medical Inc Company Overview
5.90 Newton Photonics Inc Company Overview
5.91 NIR Diagnostics Inc. (Inactive) Company Overview
5.92 Northwestern University Company Overview
5.93 Orsus Medical Ltd Company Overview
5.94 Pelikan Technologies, Inc. (Inactive) Company Overview
5.95 Pepex Biomedical, Inc. Company Overview
5.96 PharmaTech Solutions Inc Company Overview
5.97 Pignolo SpA Company Overview
5.98 POPS! Diabetes Care Inc Company Overview
5.99 PositiveID Corp Company Overview
5.100 Prediktor Medical AS Company Overview
5.101 Profusa, Inc. Company Overview
5.102 Purdue University Company Overview
5.103 Q Step Technologies, Inc. Company Overview
5.104 Roche Diabetes Care Inc Company Overview
5.105 Royal Adelaide Hospital SA Company Overview
5.106 RSP Systems A/S Company Overview
5.107 San Meditech (Huzhou) Co., Ltd. Company Overview
5.108 Senseonics Holdings, Inc. Company Overview
5.109 SensiVida Medical Technologies, Inc. (Inactive) Company Overview
5.110 Sensys Medical, Inc. Company Overview
5.111 Sentec Pte Ltd Company Overview
5.112 Senzime AB Company Overview
5.113 Shield Diagnostics Company Overview
5.114 Singapore Biomicro Pte Ltd Company Overview
5.115 Socrates Health Solutions, Inc. Company Overview
5.116 Spire Corp Company Overview
5.117 St. Louis Medical Devices Inc (Inactive) Company Overview
5.118 Stony Brook University Company Overview
5.119 TecMed Inc Company Overview
5.120 Tenax Therapeutics Inc Company Overview
5.121 Terumo Corp Company Overview
5.122 Texas A&M University Company Overview
5.123 Ultradian Diagnostics LLC Company Overview
5.124 University of Bath Company Overview
5.125 University of California Berkeley Company Overview
5.126 University of California Irvine Company Overview
5.127 University of California San Diego Company Overview
5.128 University of Central Florida Company Overview
5.129 University of South Carolina Company Overview
5.130 University of South Florida Company Overview
5.131 University of Technology Sydney Company Overview
5.132 University of Texas at Arlington Company Overview
5.133 Virginia Commonwealth University Company Overview
5.134 Vytrace, Inc. Company Overview
5.135 WaveForm Technologies Inc Company Overview
5.136 Xcellence in Bio Innovations & Technologies Pvt Ltd Company Overview
5.137 Zansors LLC Company Overview
5.138 Zyvex Corporation Company Overview

6 Blood Glucose Meters- Recent Developments
6.1 Apr 19, 2018: Roche Diabetes Care Launches the Accu-Chek Guide System and the Unique Spill-Resistant Smartpack Vial
6.2 Apr 18, 2018: Abbott Reports First-Quarter 2018 Results
6.3 Apr 18, 2018: Veritas Pharma Names Dr. Michael K. Pugsley To Advisory Board
6.4 Apr 12, 2018: Innovus Pharma Announces U.S. Food and Drug Administration Clearance of its GlucoGorx Glucose Monitoring Device Test Kit
6.5 Apr 12, 2018: Henry Schein Names Christopher Pendergast To Lead Information Technology
6.6 Apr 12, 2018: Socrates Health Solutions, Developer of Socrates Companion Noninvasive Blood Glucose Self-Monitoring Device, Announces Expanded Role of John Maynard
6.7 Apr 11, 2018: Zealand and Roche Diabetes Care enter Phase 3 study collaboration for treatment of congenital hyperinsulinism with dasiglucagon
6.8 Apr 11, 2018: Socrates Companion Noninvasive Blood Glucose Self-Monitoring Device Successfully Measures Extended Ranges for Diabetic Population
6.9 Apr 10, 2018: Tandem Diabetes Care Announces Preliminary First Quarter 2018 Results
6.10 Apr 10, 2018: Healthcare Technology Veteran Russ Johannesson Joins Glooko as CEO
6.11 Apr 10, 2018: Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program Receives 2018 William J. Gies Award
6.12 Apr 09, 2018: Henry Schein Names Mark Hillebrandt Vice President, Marketing, North America Dental Group
6.13 Apr 09, 2018: Nemaura Medical Appoints Bashir Timol Chief Business Officer
6.14 Apr 05, 2018: Sanmina Achieves FDA Registration at Its Facilities in Chennai, India
6.15 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.16 Apr 03, 2018: PositiveID Reports 2017 Results; Fourth Quarter Revenues Increase 47% Year Over Year
6.17 Mar 29, 2018: Senseonics Announces Favorable Outcome of FDA Advisory Committee on the Eversense System
6.18 Mar 28, 2018: Nemaura Medical Appoints The Ruth Group as Investor and Public Relations Counsel
6.19 Mar 28, 2018: Sanofi: Pre - quarterly Results Communication
6.20 Mar 27, 2018: FDA Authorizes Marketing of the New Dexcom G6 CGM Eliminating Need for Fingerstick Blood Testing for People with Diabetes
6.21 Mar 26, 2018: DarioHealth Receives U.S. FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter
6.22 Mar 26, 2018: Drayson Health: Positive Clinical Trial of GDm-Health
6.23 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros
6.24 Mar 22, 2018: Lee’s Pharmaceutical Holdings: Announcement Of Annual Results For The Year Ended 31 December 2017
6.25 Mar 15, 2018: Veritas Pharma Announces Appointment of Accomplished Business Development and Strategy Professional, Justin Kausel
6.26 Mar 14, 2018: EKF Diagnostics Holdings: 2017 Final results
6.27 Mar 14, 2018: Tenax Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
6.28 Mar 12, 2018: Medtronic Receives FDA Approval for Guardian Connect Continuous Glucose Monitoring (CGM) System for People Living with Diabetes
6.29 Mar 08, 2018: WaveForm Technologies Receives Favorable Decision on Critical Glucose Monitoring Patents
6.30 Mar 08, 2018: Changes to the Roche Enlarged Corporate Executive Committee
6.31 Mar 08, 2018: Sysmex: Announcement of Organizational and Personnel Changes
6.32 Mar 06, 2018: Sanofi’s Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director
6.33 Mar 05, 2018: Henry Ford Health System Appoints Adnan Munkarah As New Executive Vice President & Chief Clinical Officer
6.34 Mar 01, 2018: Nemaura Announces Expansion of Manufacturing Capabilities for SugarBEAT Commercial Launch
6.35 Mar 01, 2018: Senseonics Announces Date for FDA Advisory Panel
6.36 Mar 01, 2018: Tandem Diabetes Care Announces 2017 Financial Results
6.37 Mar 01, 2018: Senseonics Announces Date for FDA Advisory Panel
6.38 Mar 01, 2018: Callitas Health Has Big Plans For Broad Product Portfolio
6.39 Feb 21, 2018: Insulet Reports Fourth Quarter Revenue of $130.5 Million In Fourth Quarter Of 2017
6.40 Feb 21, 2018: Veritas Pharma Provides Corporate Update on Q1 2018
6.41 Feb 20, 2018: Eversense CGM System, World's Longest Lasting CGM Sensor, Announces Approval and Launch of Remote Monitoring Feature for EMEA Markets
6.42 Feb 20, 2018: New Study Demonstrates that DexCom CGM Significantly Reduces Hypoglycaemia in People with Type 1 Diabetes on MDI
6.43 Feb 20, 2018: New study shows that DexCom CGM significantly reduces hypoglycaemia in people with type 1 diabetes with multiple daily insulin injections (MDI)
6.44 Feb 20, 2018: DarioHealth Launches Sales of Dario Blood Glucose Monitoring System on Amazon Prime
6.45 Feb 20, 2018: Henry Schein Reports Record Fourth Quarter and Full Year 2017 Financial Results
6.46 Feb 19, 2018: Henry Schein And Its Dental Laboratory Business, Zahn Dental, To Showcase The Company's Latest Digital Solutions At Chicago Midwinter Dental Meeting And LMT Lab Day
6.47 Feb 16, 2018: Senzime’s Year-end Bulletin 2017
6.48 Feb 15, 2018: ProAxsis reaches the commercialization stage of its technology by reporting its first NEATstik sale
6.49 Feb 15, 2018: ConvaTec Group Annual Results 2017
6.50 Feb 15, 2018: ConvaTec Group Reports Annual Financial Results For 2017
6.51 Feb 14, 2018: Ericsson, Sony Mobile and Altair Announce LTE-M eHealth Concept Demo
6.52 Feb 13, 2018: Henry Schein Denies FTC Anti-Trust Allegations
6.53 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program
6.54 Feb 13, 2018: Changing Health and Ascensia Team up to Offer Game-changing Diabetes Support
6.55 Feb 12, 2018: DarioHealth Partners with a Leading Diabetes Clinic
6.56 Feb 12, 2018: Henry Schein Named one of the 2018 World's Most Ethical Companies by The Ethisphere Institute for the Seventh Time
6.57 Feb 09, 2018: Nemaura Medical Reports Third Quarter 2017 Financial Results
6.58 Feb 08, 2018: DarioHealth Wins Key Contract Ensuring Its Platform to be Utilized in Clinical Study
6.59 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017
6.60 Feb 08, 2018: DarioHealth Wins Key Contract Ensuring Its Platform to be Utilized in Clinical Study
6.61 Feb 08, 2018: Theraclion Accelerates its Growth in 2017
6.62 Feb 07, 2018: Sanofi Delivers 2017 Business EPS in line with Guidance
6.63 Feb 07, 2018: Theraclion announces the reinforcement of its Board of Directors with the nomination of a new Non-Executive Director: Mister Renaud Saleur
6.64 Feb 01, 2018: Roche reports good results in 2017
6.65 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables

Table 1: Blood Glucose Meters - Pipeline Products by Stage of Development
Table 2: Blood Glucose Meters - Pipeline Products by Segment
Table 3: Blood Glucose Meters - Pipeline Products by Territory
Table 4: Blood Glucose Meters - Pipeline Products by Regulatory Path
Table 5: Blood Glucose Meters - Pipeline Products by Estimated Approval Date
Table 6: Blood Glucose Meters - Ongoing Clinical Trials
Table 7: Blood Glucose Meters Companies - Pipeline Products by Stage of Development
Table 8: Blood Glucose Meters - Pipeline Products by Stage of Development
Table 9: 4a Medicom GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 10: GlucoPEARL - Product Status
Table 11: GlucoPEARL - Product Description
Table 12: A. Menarini Diagnostics Srl Pipeline Products & Ongoing Clinical Trials Overview
Table 13: GlucoMen Day - Product Status
Table 14: GlucoMen Day - Product Description
Table 15: Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 16: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Status
Table 17: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Description
Table 18: FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Status
Table 19: FreeStyle Libre Glucose Monitoring System - Consumer Version - Product Description
Table 20: Abbott Diabetes Care Inc - Ongoing Clinical Trials Overview
Table 21: FreeStyle Libre Flash Glucose Monitoring System - Children - A Comparative Study on the Accuracy, Ease of Use and Skin Reactions Between the Enlite Sensor With Guardian 2 Link Transmitter and the FreeStyle Libre Flash Glucose Sensor
Table 22: FreeStyle Libre Flash Glucose Monitoring System - Children - An Evaluation of the Usability, Skin Reactions and Accuracy of the FreeStyle Libre Flash Glucose Monitoring System
Table 23: FreeStyle Libre Flash Glucose Monitoring System - Children - Effectiveness and Safety Study of the FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations
Table 24: FreeStyle Libre Flash Glucose Monitoring System - Children - Evaluation of Two Different Glucose Monitoring Treatments and Their Impact on Time in Target, Sleep and Quality of Life in Children with Type 1 Diabetes and Primary Caregivers
Table 25: FreeStyle Libre Flash Glucose Monitoring System - Children - FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
Table 26: FreeStyle Libre Flash Glucose Monitoring System - Children - Paediatric Use of the Abbott Sensor Based Glucose Monitoring System - an Accuracy Evaluation
Table 27: FreeStyle Libre Flash Glucose Monitoring System - Children - Patients Perceptions of Using the Libre System Compared with Conventional SMBG in Adolescents with Type 1 Diabetes the Libre Sat Trial
Table 28: FreeStyle Libre Glucose Monitoring System - Consumer Version - Study about the Discrepancies Between Monitoring Data of FreeStyle libre and SMBG
Table 29: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Updated Hospital Blood Glucose Monitoring System - Product Status
Table 31: Updated Hospital Blood Glucose Monitoring System - Product Description
Table 32: Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 33: My Medibit - Product Status
Table 34: My Medibit - Product Description
Table 35: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Continuous Glucose Monitor - Product Status
Table 37: Continuous Glucose Monitor - Product Description
Table 38: Animas Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Next Generation OneTouch UltraVue Verio Platform Glucose Testing System - Product Status
Table 40: Next Generation OneTouch UltraVue Verio Platform Glucose Testing System - Product Description
Table 41: Arkal Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 42: GlucoPod CGM System - Product Status
Table 43: GlucoPod CGM System - Product Description
Table 44: Arkray Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: GLUCOCARD S - Product Status
Table 46: GLUCOCARD S - Product Description
Table 47: GLUCOCARD S onyx - Product Status
Table 48: GLUCOCARD S onyx - Product Description
Table 49: GLUCOCARD W - Product Status
Table 50: GLUCOCARD W - Product Description
Table 51: Ascensia Diabetes Care Holdings AG Pipeline Products & Ongoing Clinical Trials Overview
Table 52: CONTOUR PLUS ONE - Product Status
Table 53: CONTOUR PLUS ONE - Product Description
Table 54: Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Blood Glucose Sensor - Product Status
Table 56: Blood Glucose Sensor - Product Description
Table 57: Bar-Ilan University Pipeline Products & Ongoing Clinical Trials Overview
Table 58: Biometric Watch - Product Status
Table 59: Biometric Watch - Product Description
Table 60: Baylor University Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Portable Non-Invasive Blood Glucose Monitor - Product Status
Table 62: Portable Non-Invasive Blood Glucose Monitor - Product Description
Table 63: Biopeak Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Non-Invasive Glucose Analyzer - Product Status
Table 65: Non-Invasive Glucose Analyzer - Product Description
Table 66: Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Glucowizzard - Product Status
Table 68: Glucowizzard - Product Description
Table 69: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Smart Tattoo Glucose Sensor - Product Status
Table 71: Smart Tattoo Glucose Sensor - Product Description
Table 72: Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview
Table 73: VSM 3 Glucose Monitoring System - Product Status
Table 74: VSM 3 Glucose Monitoring System - Product Description
Table 75: Brain Beat Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Non-Invasive Glucometer - Product Status
Table 77: Non-Invasive Glucometer - Product Description
Table 78: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 79: Fluorescence Measurement Device - Product Status
Table 80: Fluorescence Measurement Device - Product Description
Table 81: Cactus Semiconductor Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 82: Blood Glucose Monitor - Product Status
Table 83: Blood Glucose Monitor - Product Description
Table 84: CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 85: Glucoband - Product Status
Table 86: Glucoband - Product Description
Table 87: Callitas Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 88: Electronic Mosquito - Product Status
Table 89: Electronic Mosquito - Product Description
Table 90: Cardiff University Pipeline Products & Ongoing Clinical Trials Overview
Table 91: Non-Invasive Blood Glucose Meter - Product Status
Table 92: Non-Invasive Blood Glucose Meter - Product Description
Table 93: CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 94: Miniaturized Implantable Continuous Glucose Monitor - Product Status
Table 95: Miniaturized Implantable Continuous Glucose Monitor - Product Description
Table 96: City, University of London Pipeline Products & Ongoing Clinical Trials Overview
Table 97: Non-Invasive Glucose Monitor - Product Status
Table 98: Non-Invasive Glucose Monitor - Product Description
Table 99: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 100: Wearable Continuous Blood Glucose Monitoring Device - Product Status
Table 101: Wearable Continuous Blood Glucose Monitoring Device - Product Description
Table 102: ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 103: Closed Loop Continuous Glucose Monitoring System - Product Status
Table 104: Closed Loop Continuous Glucose Monitoring System - Product Description
Table 105: Cyber Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 106: Cybersensors Continuous Glucose Sensor - Product Status
Table 107: Cybersensors Continuous Glucose Sensor - Product Description
Table 108: DarioHealth Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 109: Dario Blood Glucose Monitoring System - Lightning Enabled Version - Product Status
Table 110: Dario Blood Glucose Monitoring System - Lightning Enabled Version - Product Description
Table 111: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
Table 112: Integrated iSense CGM And JewelPUMP - Product Status
Table 113: Integrated iSense CGM And JewelPUMP - Product Description
Table 114: DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 115: DexCom CGM With Accu-Chek Insulin Delivery System - Product Status
Table 116: DexCom CGM With Accu-Chek Insulin Delivery System - Product Description
Table 117: Dexcom G5x - Product Status
Table 118: Dexcom G5x - Product Description
Table 119: First-Gen Verily Sensor - Product Status
Table 120: First-Gen Verily Sensor - Product Description
Table 121: G6 Continuous Glucose Monitor - Product Status
Table 122: G6 Continuous Glucose Monitor - Product Description
Table 123: Second-Gen Verily Sensor - Product Status
Table 124: Second-Gen Verily Sensor - Product Description
Table 125: DexCom Inc - Ongoing Clinical Trials Overview
Table 126: DexCom CGM With Accu-Chek Insulin Delivery System - Closed-loop Glucagon Pump for Treatment of Post-bariatric Hypoglycemia
Table 127: DexCom CGM With Accu-Chek Insulin Delivery System - Wireless Innovation for Seniors with Diabetes Mellitus: WISDM
Table 128: Dexcom G5x - Closed-loop Glucagon Pump for Treatment of Post-bariatric Hypoglycemia
Table 129: DiaMonTech GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 130: Infrared Laser Glucometer - Home Use - Product Status
Table 131: Infrared Laser Glucometer - Home Use - Product Description
Table 132: Infrared Laser Glucometer - Wearable - Product Status
Table 133: Infrared Laser Glucometer - Wearable - Product Description
Table 134: DIRAmed LLC. Pipeline Products & Ongoing Clinical Trials Overview
Table 135: Critical Care Glucose Monitor - Hospital Use - Product Status
Table 136: Critical Care Glucose Monitor - Hospital Use - Product Description
Table 137: Glucose Monitor - Home Use - Product Status
Table 138: Glucose Monitor - Home Use - Product Description
Table 139: DirectSens GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 140: Continuous Blood Glucose Monitoring System - Product Status
Table 141: Continuous Blood Glucose Monitoring System - Product Description
Table 142: Drayson Health Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 143: GDm-Health Management System - Product Status
Table 144: GDm-Health Management System - Product Description
Table 145: Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 146: Gen 2 Symphony CGM System - Product Status
Table 147: Gen 2 Symphony CGM System - Product Description
Table 148: NextGen System - Product Status
Table 149: NextGen System - Product Description
Table 150: Symphony tCGM System - Home - Product Status
Table 151: Symphony tCGM System - Home - Product Description
Table 152: Symphony tCGM System - Hospital Critical Care - Product Status
Table 153: Symphony tCGM System - Hospital Critical Care - Product Description
Table 154: Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview

List of Figures

Figure 1: Blood Glucose Meters - Pipeline Products by Stage of Development
Figure 2: Blood Glucose Meters - Pipeline Products by Segment
Figure 3: Blood Glucose Meters - Pipeline Products by Territory
Figure 4: Blood Glucose Meters - Pipeline Products by Regulatory Path
Figure 5: Blood Glucose Meters - Pipeline Products by Estimated Approval Date
Figure 6: Blood Glucose Meters - Ongoing Clinical Trials